5,7-Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties

Biochemical Pharmacology

Volumn 66, Issue 1, 2003, Pages 125-132

  Huen, Michael S Y ^a   Leung, Justin W C ^a   Ng, Wah ^a   Lui, W S ^a   Chan, Michelle N S ^a   Wong, J Tze Fei ^a   Xue, Hong ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Anxiolytics; Benzodiazepine binding site; Flavonoids; Naturally occurring; Pharmacology; Scutellaria baicalensis Georgi

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; FLAVONOID; FLUNITRAZEPAM; OROXYLIN A; SCUTELLARIA BAICALENSIS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BINDING SITE; BRAIN CORTEX; DRUG ANTAGONISM; DRUG BINDING; HERB; MALE; MOTOR COORDINATION; MUSCLE RELAXATION; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SCUTELLARIA BAICALENSIS; SEDATION; TRADITIONAL MEDICINE; TRANQUILIZING ACTIVITY;

EID: 0038005574     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00233-8     Document Type: Article

References (35)

1. Nielsen M., Frokjaer S., Braestrup C. High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro. Biochem. Pharmacol. 37(17):1988;3285-3287.
2. Medina J.H., Paladini A.C., Wolfman C., Levi de Stein M., Calvo D., Diaz L.E., Pena C. Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem. Pharmacol. 40(10):1990;2227-2231.
3. Marder M., Viola H., Wasowski C., Wolfman C., Waterman P.G., Cassels B.K., Medina J.G., Paladini A.C. 6-Bromoflavone, a high-affinity ligand for the central benzodiazepine receptors is a member of a family of active flavonoids. Biochem. Biophys. Res. Commun. 223(2):1996;384-389.
4. Viola H., Marder M., Wasowski C., Giorgi O., Paladini A.C., Medina J.H. 6,3′-Dibromoflavone and 6-nitro-3′-bromoflavone: new additions to the 6,3′-disubstituted flavone family of high-affinity ligands of the brain benzodiazepine binding site with agonistic properties. Biochem. Biophys. Res. Commun. 273(2):2000;694-698.
5. Viola H., Wolfman C., Marder M., Goutman J.D., Bianchin M., Wasowski C., Calvo D.J., Izquierdo I., Paladini A.C., Medina J.H. 6-Chloro-3′-nitroflavone is a potent ligand for the benzodiazepine binding site of the GABA(A) receptor devoid of intrinsic activity. Pharmacol. Biochem. Behav. 65(2):2000;313-320.
6. Viola H., Marder M., Nunez J., Izquierdo L., Wasowski C., Wolfman C., Ardenghi P., Barros D., Medina J.H., Paladini A.C. 6-Methyl-3′-bromoflavone, a high-affinity ligand for the benzodiazepine binding site of the GABA(A) receptor with some antagonistic properties. Biochem. Biophys. Res. Commun. 262(3):1999;643-646.
7. Tallman J.F., Thomas J.W., Gallager D.W. GABAergic modulation of benzodiazepine binding site sensitivity. Nature. 274(5669):1978;383-385.
8. Barnett R., Grace M., Boothe P., Latozek K., Neal C., Legatt D., Finegan B.A. Flumazenil in drug overdose: randomized, placebo-controlled study to assess cost effectiveness. Crit. Care Med. 27(1):1999;78-81.
9. Weinbroum A., Halpern P., Geller E. The use of flumazenil in the management of acute drug poisoning - a review. Intensive Care Med. 17(Suppl 1):1991;S32-S38.
10. Bansky G.M.P.J., Riederer R., Walser H., Ziegler W.H., Schmid M. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology. 97:1989;744-750.
11. Ma S., Du J., But P., Deng X., Zhang Y., Ooi V., Xu H., Lee S., Lee S. Antiviral Chinese medicinal herbs against respiratory syncytial virus. J. Ethnopharmacol. 79(2):2002;205-211.
12. Wakabayashi I., Yasui K. Wogonin inhibits inducible prostaglandin E(2) production in macrophages. Eur. J. Pharmacol. 406(3):2000;477-481.
13. Shieh D., Liu L., Lin C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res. 20(5A):2000;2861-2865.
14. 2+ elevation by reducing phospholipase C activity in C6 rat glioma cells. J. Pharm. Pharmacol. 50(10):1998;1179-1182.
15. Hui K.M., Wang X.H., Xue H. Interaction of flavones from the roots of Scutellaria baicalensis with the benzodiazepine site. Planta Med. 66(1):2000;91-93.
16. Hui K.M., Huen M.S.Y., Wang H.Y., Zheng H., Sigel E., Baur R., Ren H., Li Z.W., Wong J.T., Xue H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem. Pharmacol. 64(9):2002;1415-1424.
17. Hu B.H., Liu Y.L. Studies on the structures of new flavonoids from the root of Scutellaria amoena. Yao Xue Xue Bao. 24(3):1989;200-206.
18. Vogel HG, Vogel WH. Drug discovery and evaluation: pharmacology assay. New York: Springer; 1997.
19. File S.E., Day S. Effects of time of day and food deprivation on exploratory activity in the rat. Anim. Behav. 20(4):1972;758-762.
20. Rodgers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52(2):1995;297-303.
21. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49(1):1994;171-176.
22. Bonetti E.P., Pieri L., Cumin R., Schaffner R., Pieri M., Gamzu E.R., Muller R.K., Haefely W. Benzodiazepine antagonist Ro15-1788: neurological and behavioral effects. Psychopharmacology (Berlin). 78(1):1982;8-18.
23. Medina J.H., Viola H., Wolfman C., Marder M., Wasowski C., Calvo D., Paladini A.C. Overview - flavonoids: a new family of benzodiazepine receptor ligands. Neurochem. Res. 22(4):1997;419-425.
24. Marder M., Paladini A.C. GABA(A)-receptor ligands of flavonoid structure. Curr. Top. Med. Chem. 2(8):2002;853-867.
25. Viswanathan S., Sambantham P.T., Reddy K., Kameswaran L. Gossypin-induced analgesia in mice. Eur. J. Pharmacol. 98(2):1984;289-291.
26. Wang Q., Han Y., Xue H. Ligands of GABAA receptor benzodiazepine binding site. CNS Drug Rev. 5:1999;124-144.
27. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., Martin J.R., Bluethmann H., Mohler H. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature. 401(6755):1999;796-800.
28. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., Fritschy J.M., Rulicke T., Bluethmann H., Mohler H., Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 290(5489):2000;131-134.
29. Crestani F., Low K., Keist R., Mandelli M., Mohler H., Rudolph U. Molecular targets for the myorelaxant action of diazepam. Mol. Pharmacol. 59(3):2001;442-445.
30. Crestani F., Martin J.R., Mohler H., Rudolph U. Mechanism of action of the hypnotic zolpidem in vivo. Br. J. Pharmacol. 131(7):2000;1251-1254.
31. Crestani F., Martin J.R., Mohler H., Rudolph U. Resolving differences in GABAA receptor mutant mouse studies. Nat. Neurosci. 3(11):2000;1059.
32. Marder M., Viola H., Bacigaluppo J.A., Colombo M.I., Wasowski C., Wolfman C., Medina J.H., Ruveda E.A., Paladini A.C. Detection of benzodiazepine receptor ligands in small libraries of flavone derivatives synthesized by solution phase combinatorial chemistry. Biochem. Biophys. Res. Commun. 249(2):1998;481-485.
33. Dekermendjian K., Kahnberg P., Witt M.R., Sterner O., Nielsen M., Liljefors T. Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex. J. Med. Chem. 42(21):1999;4343-4350.
34. Marder M., Estiu G., Blanch L., Viola H., Wasowski C., Medina J., Paladini A. Molecular modeling and QSAR analysis of the interaction of flavone derivatives with the benzodiazepine binding site of the GABA(A) receptor complex. Bioorg. Med. Chem. 9(2):2001;323-335.
35. Huang X., Liu T., Gu J., Luo X., Ji R., Cao Y., Xue H., Wong J.T., Wong B.L., Pei G., Jiang H., Chen K. 3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors. J. Med. Chem. 44(12):2001;1883-1891.